Seeing my three biggest positions are ARIA, MDVN and PCYC, my portfolio would very much disagree with you, to date at least. :)
You could make the same argument about drug development in general - clearly most drugs are going to fail. The exceptions are not, and it is our job to find the exceptions before Wall Street does.